Evidence map›Paper›PMID 38631329›Full record

ArticleNanotechnology2024

Optimizing the performance of silica nanoparticles functionalized with a near-infrared fluorescent dye for bioimaging applications.

Evie G Ehrhorn, Paul Lovell, Denis Svechkarev, Svetlana Romanova, Aaron M Mohs

Abstract read
In one paragraph

Article in Nanotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Evie G EhrhornEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.ORCID 0000-0002-3758-9942
Paul LovellFred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.
Denis SvechkarevDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.
Svetlana RomanovaDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.
Aaron M MohsFred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.ORCID 0000-0002-9353-5404

Funding

Translational Imaging and Behavioral Assessment (TIBA) CoreP20GM130447 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Anna Dunaevsky · 2020 to 2026
$20.7M
Nebraska Center for Nanomedicine- Pilot ProjectsP30GM127200 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI OUPICKY, DAVID · 2018 to 2022
$5.7M
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancerR01CA259080 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Aaron M. Mohs · 2022 to 2026
$1.8M
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging ApplicationsR21CA212500 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MOHS, AARON M. · 2017 to 2019
$596k
NCI NIH HHS R01 CA259080NCI NIH HHS R21 CA212500NIGMS NIH HHS P20 GM130447NIGMS NIH HHS P30 GM127200
6 · The paper itself

Abstract

Modified fluorescent nanoparticles continue to emerge as promising candidates for drug delivery, bioimaging, and labeling tools for various biomedical applications. The ability of nanomaterials to fluorescently label cells allow for the enhanced detection and understanding of diseases. Silica nanoparticles have a variety of unique properties that can be harnessed for many different applications, causing their increased popularity. In combination with an organic dye, fluorescent nanoparticles demonstrate a vast range of advantageous properties including long photostability, surface modification, and signal amplification, thus allowing ease of manipulation to best suit bioimaging purposes. In this study, the Stöber method with tetraethyl orthosilicate (TEOS) and a fluorescent dye sulfo-Cy5-amine was used to synthesize fluorescent silica nanoparticles. The fluorescence spectra, zeta potential, quantum yield, cytotoxicity, and photostability were evaluated. The increased intracellular uptake and photostability of the dye-silica nanoparticles show their potential for bioimaging.

Indexed as

Fluorescent DyesNanoparticlesSilicon DioxideCarbocyaninesCell SurvivalHumansOptical ImagingCarbocyaninesFluorescent DyesSilicon Dioxidefluorescence imagingphotostabilitysilica nanoparticlesstöber method

Identifiers

PMID38631329
PMCPMC11216106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.